Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Radiat Res ; 191(1): 31-42, 2019 01.
Article in English | MEDLINE | ID: mdl-30339056

ABSTRACT

Several investigators performing bone marrow transplantation studies have previously reported sporadic increases in mortality that were associated with pronounced swelling in the face, head and neck of mice. Over the past few years, we and others have noted an increasing number of experiments in which mice that have received total-body irradiation (TBI) or partial-body irradiation (PBI) develop swollen muzzles, drastic thickening of the upper lip and redness, bruising and/or swelling around the nose and muzzle and sometimes over the top of the head. We refer to this rapid and extreme swelling after irradiation as swollen muzzle syndrome (SMS). The development of SMS postirradiation is associated with morbidity that occurs earlier than would be expected from the traditional hematopoietic acute radiation syndrome (H-ARS), and has impeded studies in several laboratories attempting to evaluate medical countermeasures (MCM) against radiation. However, little has been done to characterize this somewhat unpredictable radiation effect. To investigate the cause and etiology of SMS, data from three different laboratories collected over a seven-year period from 100 MCM 30-day survival studies using mice from different vendors were retrospectively analyzed to determine the time of onset, progression and incidence of SMS in male and female mice exposed to various doses of ionizing radiation. An additional study compared incidence and etiology of SMS in mice from two different vendors (identified as vendors A and B) after exposure to the LD50/30 (X rays). Mice presenting with SMS, as well as non-SMS (irradiated) control mice, were necropsied to determine microbial status of the blood, heart, spleen, liver, kidney and muzzle tissue. Only mice from vendor A (20%) developed SMS. While the number of bacterial species isolated from various tissues of SMS and non-SMS mice was not different, the number of tissues positive for bacteria was significantly greater in SMS mice. At least one tissue in 83% of SMS mice from vendor A tested positive for Streptococcus agalactiae [group B beta Streptococcus (GBS)], compared to 25% of non-SMS mice from vendor A, and 0% of non-SMS mice from vendor B. In addition, all mice from vendor A with SMS had at least one tissue with >104 CFU/g, with GBS as the predominant bacterium, compared to only 25% of non-SMS mice from vendor A, and 0% of non-SMS mice from vendor B. The incidence and magnitude of GBS growth in cultures correlated with the onset of SMS; the earliest and heaviest infections occurred in mice presenting with SMS on days 5-6 postirradiation. The majority of SMS mice (5 out of 6) had positive blood cultures, with the same bacterial strain isolated from other tissues, suggesting systemic translocation via the bloodstream. We propose that testing of mice and the identification of the microorganisms frequently associated with SMS may provide guidance for selection of antimicrobials for use by other investigators in studies evaluating potential MCM, and for the ordering, handling and care of immunodeficient mice or mice that are to be rendered immunodeficient after acute irradiation.


Subject(s)
Edema/etiology , Face/radiation effects , Head/radiation effects , Neck/radiation effects , Radiation Injuries, Experimental/etiology , Acute Radiation Syndrome/etiology , Acute Radiation Syndrome/pathology , Animals , Edema/pathology , Face/pathology , Female , Head/pathology , Male , Mice , Mice, Inbred C57BL , Neck/pathology , Radiation Injuries, Experimental/pathology , Retrospective Studies , Whole-Body Irradiation/adverse effects
2.
Injury ; 47(12): 2679-2682, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27461780

ABSTRACT

BACKGROUND: Temporary external fixators are often used to stabilize fractures when definitive fracture surgery must be delayed. Sometimes, external fixators are left in place during repeat operations, including definitive internal fixation of tibial pilon and tibial plateau fractures. It is unknown how well current surgical preparation sterilizes these devices, which become part of the surgical field. Our hypothesis was that our institution's standard surgical preparation creates a low rate of culture-positive environments on external fixators at the time of surgical skin incision. METHODS: We prospectively consented and enrolled patients to obtain cultures (48 patients, 55 external fixators, 165 sets of culture data). After standard preparation and immediately before incision, cultures were obtained from three sites on each external fixator: 1) most distal pin 1cm from pin-skin interface, 2) most distal bar at midpoint between pin and clamp connectors, and 3) most distal clamp at bar-clamp interface. Our standard preparation for patients with external fixation in place is to don sterile gloves and wipe down all components of the external fixator with 70% alcohol-soaked sterile 4×4in gauze sponges before skin preparation. The skin and external fixator are then prepped in the usual fashion with ChloraPrep for closed wounds or with povidone iodine scrub and paint for open wounds. Swabs were processed and organisms from cultures identified. Clinicians were blinded to study results until study completion. RESULTS: Two of 165 cultures (1.2%; 95% confidence interval [CI]: 0-2.9%) were positive for common pathogens sometimes observed in surgical site infection. Four cultures (2.4%; 95% CI: 0-4.8%) had pathogens that are rarely associated with surgical site infection, and four (2.4%; 95% CI: 0-4.8%) had nonpathogenic organisms. CONCLUSION: Using 70% alcohol on external fixators plus either ChloraPrep for closed wounds or povidone iodine for open wounds seems to result in a low rate of positive cultures. Most species that were isolated are infrequently identified as sources of surgical site infections. This preparation protocol might be effective at producing a relatively clean environment at the time of surgery for patients with external fixators already in place.


Subject(s)
2-Propanol/pharmacology , Anti-Infective Agents, Local/pharmacology , External Fixators/microbiology , Fractures, Open/surgery , Povidone-Iodine/pharmacology , Sterilization/methods , Surgical Wound Infection/drug therapy , Tibial Fractures/surgery , Adult , Aged , Female , Fracture Fixation, Internal , Fractures, Open/complications , Fractures, Open/microbiology , Humans , Male , Middle Aged , Orthopedics , Prospective Studies , Skin/microbiology , Surgical Wound Infection/microbiology , Surgical Wound Infection/prevention & control , Tibial Fractures/complications , Tibial Fractures/microbiology , Treatment Outcome , United States , Wound Healing , Young Adult
3.
J Infect Dis ; 205(9): 1374-81, 2012 May 01.
Article in English | MEDLINE | ID: mdl-22454468

ABSTRACT

BACKGROUND: Acute gastroenteritis (AGE) remains a common cause of clinic visits and hospitalizations in the United States, but the etiology is rarely determined. METHODS: We performed a prospective, multicenter emergency department-based study of adults with AGE. Subjects were interviewed on presentation and 3-4 weeks later. Serum samples, rectal swab specimens, and/or whole stool specimens were collected at presentation, and serum was collected 3-4 weeks later. Fecal specimens were tested for a comprehensive panel of viral, bacterial, and parasitic pathogens; serum was tested for calicivirus antibodies. RESULTS: Pathogens were detected in 25% of 364 subjects, including 49% who provided a whole stool specimen. The most commonly detected pathogens were norovirus (26%), rotavirus (18%), and Salmonella species (5.3%). Pathogens were detected significantly more often from whole stool samples versus a rectal swab specimen alone. Nine percent of subjects who provided whole stool samples had >1 pathogen identified. CONCLUSIONS: Viruses, especially noroviruses, play a major role as agents of severe diarrhea in adults. Further studies to confirm the unexpectedly high prevalence of rotaviruses and to explore the causes of illness among patients from whom a pathogen cannot be determined are needed. Studies of enteric pathogens should require the collection of whole stool samples.


Subject(s)
Emergency Service, Hospital , Gastroenteritis/etiology , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Caliciviridae/isolation & purification , Caliciviridae/pathogenicity , Caliciviridae Infections/complications , Diarrhea/epidemiology , Diarrhea/microbiology , Diarrhea/virology , Feces/microbiology , Feces/virology , Female , Gastroenteritis/microbiology , Gastroenteritis/parasitology , Gastroenteritis/virology , Hospitalization , Humans , Interviews as Topic , Male , Middle Aged , Prevalence , Prospective Studies , Salmonella/isolation & purification , Salmonella/pathogenicity , Salmonella Infections/complications , Specimen Handling/methods , Surveys and Questionnaires , United States/epidemiology , Young Adult
4.
J Endod ; 37(10): 1337-44, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21924178

ABSTRACT

INTRODUCTION: The presence of antibiotic resistance genes in endodontic microorganisms might render the infection resistant to common antibiotics. The aims of this project were to identify selected antibiotic resistance genes in primary and persistent endodontic infections and to determine the effectiveness of contemporary endodontic procedures in eliminating bacteria with these genes. METHODS: In patients undergoing primary endodontic treatment or retreatment, the root canals were aseptically accessed and sampled before endodontic procedures as well as after contemporary chemomechanical preparation and medication with calcium hydroxide. Identification of the following antibiotic resistance genes was performed by using polymerase chain reaction: bla(TEM-1), cfxA, blaZ, tetM, tetW, tetQ, vanA, vanD, and vanE. Limited phenotypic identification and antibiotic susceptibility verification were also performed. RESULTS: Overall, there were 45 specimens available for analysis, 30 from primary and 15 from persistent endodontic infections. In preoperative specimens, only bla(TEM-1) was significantly more prevalent in primary versus persistent infections (P = .04). After contemporary treatment procedures, there was an overall reduction in prevalence of these genes (P < .001). bla(TEM-1) and tetW were significantly reduced (P < .05), cfxA, blaZ, and tetQ were eliminated, but there was no change in tetM. No specimens contained vanA, vanD, or vanE. Antibiotic susceptibility testing showed significant differences among the antibiotics (P < .001) and general concordance with the gene findings. CONCLUSIONS: bla(TEM)(-1) was more prevalent in primary than persistent infections. Vancomycin resistance was not present. The genes identified were reduced with treatment except for tetM. Genetic testing might be useful as a screening tool for antibiotic resistance.


Subject(s)
Dental Pulp Diseases/microbiology , Drug Resistance, Bacterial/genetics , Genes, Bacterial , Periapical Periodontitis/microbiology , Acute Disease , Adult , Aged , Aged, 80 and over , Chronic Disease , DNA, Bacterial/genetics , Dental Pulp Diseases/therapy , Humans , Microbial Sensitivity Tests , Middle Aged , Periapical Periodontitis/therapy , Root Canal Irrigants/therapeutic use , Root Canal Preparation , Tetracycline Resistance/genetics , Vancomycin Resistance/genetics , Young Adult , beta-Lactam Resistance/genetics
5.
Infect Control Hosp Epidemiol ; 32(3): 244-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21460509

ABSTRACT

OBJECTIVE: To assess risk factors for methicillin-resistant Staphylococcus aureus (MRSA) acquisition among extended care residents focusing on level of care (residential vs rehabilitation) and room placement with an MRSA-positive resident. DESIGN: Prospective cohort study. SETTING: Extended care units at 2 healthcare systems in Maryland. PARTICIPANTS: Four hundred forty-three residents with no history of MRSA and negative MRSA surveillance cultures of the anterior nares and areas of skin breakdown at enrollment. METHODS: Follow-up cultures were collected every 4 weeks and/or at discharge for a period of 12 weeks. Study data were collected by a research nurse from the medical staff and the electronic medical records. Cox proportional hazards modeling was used to calculate adjusted hazards ratios (aHRs) and 95% confidence intervals (CIs). RESULTS: Residents in rehabilitation care had 4-fold higher risk of MRSA acquisition compared with residents in residential care (hazard ratio [HR], 4. [95% CI, 2.2-8.8]). Being bedbound was significantly associated with MRSA acquisition in both populations (residential care, aHR, 4.3 [95% CI, 1.5-12.2]; rehabilitation care, aHR, 4.8 [95% CI, 1.2-18.7]). Having an MRSA-positive roommate was not significantly associated with acquisition in either population (residential care, aHR, 1.4 [95% CI, 0.5-3.9]; rehabilitation care, aHR, 0.5 [95% CI, 0.1-2.2]); based on concordant spa typing, only 2 of 8 residents who acquired MRSA and had room placement with an MRSA-positive resident acquired their MRSA isolate from their roommate. CONCLUSION: Residents in rehabilitation care appear at higher risk and have different risk factors for MRSA acquisition compared to those in residential care.


Subject(s)
Cross Infection/epidemiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Nursing Homes , Rehabilitation Centers , Staphylococcal Infections/epidemiology , Aged , Aged, 80 and over , DNA, Bacterial/analysis , Female , Humans , Kaplan-Meier Estimate , Male , Methicillin-Resistant Staphylococcus aureus/genetics , Middle Aged , Patients' Rooms , Proportional Hazards Models , Prospective Studies , Risk Factors
6.
J Clin Microbiol ; 48(11): 4253-5, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20810775

ABSTRACT

Mupirocin is widely used to decolonize patients carrying Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA). The aim of this study was to determine the presence of high-level mupirocin resistance by a new commercially available mupA genotypic diagnostic product, mupA EVIGENE assay (AdvanDx).


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Drug Resistance, Bacterial , Mupirocin/pharmacology , Nuclear Proteins/genetics , Staphylococcus aureus/drug effects , DNA, Bacterial/genetics , Genotype , Humans , Microbial Sensitivity Tests/methods , Nucleic Acid Hybridization/methods , Sensitivity and Specificity
7.
Infect Control Hosp Epidemiol ; 31(8): 838-41, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20569116

ABSTRACT

We performed a retrospective cohort study (n=129) to assess whether residents of extended care facilities who were initially colonized or infected with the methicillin-resistant Staphylococcus aureus (MRSA) strain USA300 were less likely to have prolonged colonization than were residents colonized or infected with other MRSA strains. We found no difference in prolonged colonization (adjusted odds ratio, 1.1 [95% confidence interval, 0.5-2.4]).


Subject(s)
Carrier State/epidemiology , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Skilled Nursing Facilities , Staphylococcal Infections/epidemiology , Veterans/statistics & numerical data , Aged , Aged, 80 and over , Carrier State/microbiology , Cohort Studies , Female , Humans , Male , Maryland , Methicillin-Resistant Staphylococcus aureus/genetics , Middle Aged , Retrospective Studies , Risk Factors , Staphylococcal Infections/microbiology , United States , United States Department of Veterans Affairs
8.
Antimicrob Agents Chemother ; 54(8): 3143-8, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20479207

ABSTRACT

The present study aimed to determine the frequency of methicillin-resistant Staphylococcus aureus (MRSA)-positive clinical culture among hospitalized adults in different risk categories of a targeted MRSA active surveillance screening program and to assess the utility of screening in guiding empiric antibiotic therapy. We completed a prospective cohort study in which all adults admitted to non-intensive-care-unit locations who had no history of MRSA colonization or infection received targeted screening for MRSA colonization upon hospital admission. Anterior nares swab specimens were obtained from all high-risk patients, defined as those who self-reported admission to a health care facility within the previous 12 months or who had an active skin infection on admission. Data were analyzed for the subcohort of patients in whom an infection was suspected, determined by (i) receipt of antibiotics within 48 h of admission and/or (ii) the result of culture of a sample for clinical analysis (clinical culture) obtained within 48 h of admission. Overall, 29,978 patients were screened and 12,080 patients had suspected infections. A total of 46.4% were deemed to be at high risk on the basis of the definition presented above, and 11.1% of these were MRSA screening positive (colonized). Among the screening-positive patients, 23.8% had a sample positive for MRSA by clinical culture. Only 2.4% of patients deemed to be at high risk but found to be screening negative had a sample positive for MRSA by clinical culture, and 1.6% of patients deemed to be at low risk had a sample positive for MRSA by clinical culture. The risk of MRSA infection was far higher in those who were deemed to be at high risk and who were surveillance culture positive. Targeted MRSA active surveillance may be beneficial in guiding empiric anti-MRSA therapy.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Hospitalization , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Population Surveillance/methods , Practice Guidelines as Topic , Staphylococcal Infections/epidemiology , Academic Medical Centers , Adult , Baltimore/epidemiology , Cross Infection/drug therapy , Cross Infection/epidemiology , Female , Humans , Male , Mass Screening/methods , Methicillin-Resistant Staphylococcus aureus/drug effects , Middle Aged , Nasal Cavity/microbiology , Risk Assessment , Risk Factors , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology
9.
Clin Infect Dis ; 50 Suppl 1: S26-33, 2010 Jan 01.
Article in English | MEDLINE | ID: mdl-20067390

ABSTRACT

BACKGROUND: The rationale and lessons learned through the evolution of the National Survey for the Susceptibility of Bacteroides fragilis Group from its initiation in 1981 through 2007 are reviewed here. The survey was conceived in 1980 to track emerging antimicrobial resistance in Bacteroides species. METHODS: Data from the last 11 years of the survey (1997-2007), including 6574 isolates from 13 medical centers, were analyzed for in vitro antimicrobial resistance to both frequently used and newly developed anti-anaerobic agents. The minimum inhibitory concentrations of the antibiotics were determined using agar dilution in accordance with Clinical and Laboratory Standards Institute recommendations. RESULTS: The analyses revealed that the carbapenems (imipenem, meropenem, ertapenem, and doripenem) and piperacillin-tazobactam were the most active agents against these pathogens, with resistance rates of 0.9%-2.3%. In the most recent 3 years of the survey (2005-2007), resistance to some agents was shown to depend on the species, such as ampicillin-sulbactam against Bacteroides distasonis (20.6%) and tigecycline against Bacteroides uniformis and Bacteroides eggerthii ( approximately 7%). Very high resistance rates (>50%) were noted for moxifloxacin and trovafloxacin, particularly against Bacteroides vulgatus. During that period of study, non-B. fragilis Bacteroides species had >40% resistance to clindamycin. Metronidazole-resistant Bacteroides strains were also first reported during that period. CONCLUSIONS: In summary, resistance to antibiotics was greater among non-B. fragilis Bacteroides species than among B. fragilis and was especially greater among species with a low frequency of isolation, such as Bacteroides caccae and B. uniformis. The emergence of resistance among the non-B. fragilis Bacteroides species underscores the need for speciation of B. fragilis group isolates and for clinicians to be aware of associations between species and drug resistance.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria, Anaerobic/drug effects , Bacteroides fragilis/drug effects , Bacteroides/drug effects , Drug Resistance, Bacterial , Bacteremia/microbiology , Bacteroides/classification , Bacteroides/isolation & purification , Bacteroides Infections/microbiology , Bacteroides fragilis/isolation & purification , Data Collection , Humans , Microbial Sensitivity Tests
10.
J Infect Dis ; 200(6): 900-5, 2009 Sep 15.
Article in English | MEDLINE | ID: mdl-19673646

ABSTRACT

BACKGROUND: Imipenem-resistant Pseudomonas aeruginosa (IRPA) is an emerging problem. The causal role of antibiotic selective pressure versus patient-to-patient transmission has not been assessed using a large cohort. METHODS: Patients who were admitted to the medical and surgical intensive care units (ICUs) at the University of Maryland Medical Center from 2001 through 2006 had multiple perianal culture samples collected. Using pulsed-field gel electrophoresis (PFGE), the number of patients who acquired IRPA as a result of patient-to-patient transmission was determined. We also analyzed a subset of patients who had a previous surveillance culture that grew an imipenem-susceptible P. aeruginosa (ISPA) and a subsequent culture that grew IRPA. RESULTS: Our cohort consisted of 7071 patients. Three hundred patients were colonized with IRPA. 151 patients had positive culture findings at ICU admission, and 149 patients acquired an IRPA. Among the patients who acquired IRPA, 46 (31%) had a PFGE pattern similar to that for another isolate, and 38 (26%) were found to be colonized with an ISPA on the basis of earlier culture results. Of the 38-patient subset, 28 (74%) had identical PFGE patterns. CONCLUSIONS: Our data showed that, of those cases of IRPA acquisition, 46 (31%) were defined as cases of patient-to-patient transmission, and 28 (19%) were cases of acquisition by the patients' endogenous flora.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Imipenem/pharmacology , Intensive Care Units , Pseudomonas Infections/transmission , Pseudomonas aeruginosa/drug effects , Adult , Cross Infection/microbiology , Cross Infection/transmission , Electrophoresis, Gel, Pulsed-Field , Humans , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/genetics
11.
Infect Control Hosp Epidemiol ; 30(4): 313-8, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19239380

ABSTRACT

BACKGROUND: The anterior nares are the most sensitive single site for detecting methicillin-resistant Staphylococcus aureus (MRSA) colonization. Colonization patterns of USA300 MRSA colonization are unknown. OBJECTIVES: To assess whether residents of extended care facilities who are colonized with USA300 MRSA have different nares or skin colonization findings, compared with residents who are colonized with non-USA300 MRSA strains. METHODS: The study population included residents of 5 extended care units in 3 separate facilities who had a recent history of MRSA colonization. Specimens were obtained weekly for surveillance cultures from the anterior nares, perineum, axilla, and skin breakdown (if present) for 3 weeks. MRSA isolates were categorized as USA300 MRSA or non-USA300 MRSA. RESULTS: Of the 193 residents who tested positive for MRSA, 165 were colonized in the anterior nares, and 119 were colonized on their skin. Eighty-four percent of USA300 MRSA-colonized residents had anterior nares colonization, compared with 86% of residents colonized with non-USA300 MRSA (P= .80). Sixty-six percent of USA300 MRSA-colonized residents were colonized on the skin, compared with 59% of residents colonized with non-USA300 MRSA (P= .30). CONCLUSIONS: Colonization patterns of USA300 MRSA and non-USA300 MRSA are similar in residents of extended care facilities. Anterior nares cultures will detect most--but not all--people who are colonized with MRSA, regardless of whether it is USA300 or non-USA300 MRSA.


Subject(s)
Community-Acquired Infections/epidemiology , Methicillin-Resistant Staphylococcus aureus , Nose/microbiology , Skilled Nursing Facilities , Skin/microbiology , Staphylococcal Infections/epidemiology , Baltimore , Community-Acquired Infections/microbiology , Female , Hospitals, Veterans , Humans , Male , Methicillin Resistance , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/growth & development , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Middle Aged , Prevalence , Staphylococcal Infections/microbiology
12.
Antimicrob Agents Chemother ; 52(10): 3558-63, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18663022

ABSTRACT

Hospital-acquired vancomycin-resistant enterococcal bacteremia has been associated with increased hospital costs, length of stay, and mortality. The peptide nucleic acid fluorescent in situ hybridization (PNA FISH) test for Enterococcus faecalis and other enterococci (EFOE) is a multicolor probe that differentiates E. faecalis from other enterococcal species within 3 h directly from blood cultures demonstrating gram-positive cocci in pairs and chains (GPCPC). A quasiexperimental study was performed over two consecutive years beginning in 2005 that identified GPCPC by conventional microbiological methods, and in 2006 PNA FISH was added with a treatment algorithm developed by the antimicrobial team (AMT). The primary outcome assessed was the time from blood culture draw to the implementation of effective antimicrobial therapy before and after PNA FISH. The severity of illness, patient location, and empirical antimicrobial therapy were measured. A total of 224 patients with hospital-acquired enterococcal bacteremia were evaluated, with 129 in the preintervention period and 95 in the PNA FISH period. PNA FISH identified E. faecalis 3 days earlier than conventional cultures (1.1 versus 4.1 days; P < 0.001). PNA FISH identified Enterococcus faecium a median 2.3 days earlier (1.1 versus 3.4 days; P < 0.001) and was associated with statistically significant reductions in the time to initiating effective therapy (1.3 versus 3.1 days; P < 0.001) and decreased 30-day mortality (26% versus 45%; P = 0.04). The EFOE PNA FISH test in conjunction with an AMT treatment algorithm resulted in earlier initiation of appropriate empirical antimicrobial therapy for patients with hospital-acquired E. faecium bacteremia.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacteremia/drug therapy , Bacteremia/microbiology , Cross Infection/drug therapy , Cross Infection/microbiology , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/microbiology , In Situ Hybridization, Fluorescence/methods , Peptide Nucleic Acids/genetics , Adult , Aged , Aged, 80 and over , Algorithms , Enterococcus faecalis/drug effects , Enterococcus faecalis/genetics , Enterococcus faecalis/isolation & purification , Enterococcus faecium/drug effects , Enterococcus faecium/genetics , Enterococcus faecium/isolation & purification , Female , Humans , Male , Middle Aged , Molecular Probes/genetics , Time Factors , Vancomycin Resistance/genetics
13.
Infect Control Hosp Epidemiol ; 29(5): 430-6, 2008 May.
Article in English | MEDLINE | ID: mdl-18419365

ABSTRACT

OBJECTIVE: To determine the range and the mode of germicidal activity of sterilants generated by a nonthermal plasma sterilization system for microorganisms. METHODS: Representative bacteria, spores, viruses, bacteriophages, and fungi were exposed to the plasma cycle and the residual viability was measured in vitro. To assess the mode of lethal injury, Escherichia coli, Staphylococcus aureus, Bacillus atrophaeus, and bacteriophages were exposed to the plasma cycle, and the effects of the plasma-generated sterilants on the biological parameters were determined. RESULTS: There were at least 4-6 log reductions in viability for all microorganisms after 10 minutes of exposure to the plasma cycle. Electron micrographs and studies of the inhibition of bacteriophage infectivity suggested that the primary injury is to the organisms' cell envelopes. The plasma cycle also denatured isolated bacterial proteins and inactivated bacteriophages, but it had no effect on isolated DNA and bacterial proteins within exposed bacteria. CONCLUSION: Nonthermal plasma, which is produced at atmospheric temperature and pressure, generates sterilants that kill high concentrations of microorganisms and inactivate viruses during a 10-minute exposure. The primary injury appears to be at the surface structures of the organisms. This suggests that nonthermal plasma has utility for sterilization of heat-sensitive medical materials and devices.


Subject(s)
Bacillus/growth & development , Bacteriophages/growth & development , Escherichia coli/growth & development , Gases , Staphylococcus aureus/growth & development , Sterilization/methods , Bacillus/classification , Bacillus/ultrastructure , Bacteriophages/ultrastructure , Colony Count, Microbial , Escherichia coli/ultrastructure , Microscopy, Electron , Spores, Bacterial/growth & development , Spores, Bacterial/ultrastructure , Staphylococcus aureus/ultrastructure , Sterilization/instrumentation
14.
J Clin Microbiol ; 46(1): 50-5, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17977998

ABSTRACT

We evaluated the performance of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization (PNA FISH) method, a rapid two-color assay for detection of C. albicans and C. glabrata, in a multicenter study. The assay is designed for use directly from positive blood culture bottles in a FISH format. Intact, fixed cells are labeled fluorescent green (C. albicans) or fluorescent red (C. glabrata) by rRNA hybridization of fluorophore-labeled PNA probes. Results are available <3 h after cultures signal positive. An evaluation of 197 routine blood culture bottles newly positive for yeast by Gram staining was performed at five hospitals. The sensitivities of detection for C. albicans, and C. glabrata were 98.7% (78/79) and 100% (37/37), respectively, and the specificity for both components of the assay was 100% (82/82). The assay was also evaluated with 70 fungal reference strains and was challenged in the BacT/ALERT microbiological detection system with spiked blood culture bottles. These results support the use of the assay for rapid, simultaneous identification of C. albicans and C. glabrata in positive blood culture bottles. This rapid assay may aid in the selection of initial antifungal drugs, leading to improved patient outcomes.


Subject(s)
Blood/microbiology , Candida albicans/isolation & purification , Candida glabrata/isolation & purification , In Situ Hybridization, Fluorescence/methods , Peptide Nucleic Acids , Candida albicans/genetics , Candida glabrata/genetics , Candidiasis/diagnosis , Humans , Sensitivity and Specificity
15.
Infect Control Hosp Epidemiol ; 28(7): 877-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17564994

ABSTRACT

We assessed methicillin-resistant Staphylococcus aureus (MRSA) infection and colonization in hospitalized prisoners. Of 434 admission surveillance cultures, 58 (13%) were positive for MRSA. The sensitivity of admission surveillance cultures of samples from the anterior nares was 72% and increased to 84% when the calculation included cultures of wound samples. Hospitalized prisoners are at high risk for MRSA infection and colonization, and surveillance should include cultures of nares and wound samples.


Subject(s)
Cross Infection/microbiology , Methicillin Resistance , Prisoners , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , Carrier State/microbiology , Cohort Studies , Cross Infection/drug therapy , Cross Infection/epidemiology , Female , Humans , Male , Maryland/epidemiology , Nasal Lavage Fluid/microbiology , Prospective Studies , Sex Factors , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology , Wound Infection/microbiology
16.
Infect Control Hosp Epidemiol ; 27(7): 762-3, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16807855

ABSTRACT

The prevalence of multidrug-resistant bacteria in the community is increasing, and companion animals serve as a potential reservoir for such bacteria. This report describes a case of a companion dog that was treated with multiple courses of antibiotics for a chronic illness and transmitted multidrug-resistant bacteria to a human through a bite.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bites and Stings , Escherichia coli Infections/transmission , Escherichia coli/drug effects , Adult , Animals , Anti-Bacterial Agents/pharmacology , Dogs , Drug Resistance, Microbial , Drug Resistance, Multiple , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Female , Humans
17.
J Antimicrob Chemother ; 58(1): 154-8, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16636084

ABSTRACT

OBJECTIVES: To evaluate the impact of the rapid differentiation of Staphylococcus aureus from coagulase-negative staphylococci (CoNS) in blood cultures using peptide nucleic acid fluorescence in situ hybridization (PNA FISH) on vancomycin usage, length of patient hospital stay and hospital costs. DESIGN: This was a retrospective, cost-effective analysis of PNA FISH in its initial 3 month implementation period in 2004 in a 650 bed academic medical centre. Blood cultures with Gram-positive cocci in clusters (GPCC) that were negative for S. aureus using the PNA FISH assay were compared with an untested control group in the same period that had similar illness severity and location. We evaluated the effectiveness of the early identification of CoNS by ruling out S. aureus in conjunction with an antimicrobial team (AMT) on antimicrobial therapy, patient length of stay and hospital costs. RESULTS: A total of 139 blood cultures positive with GPCC had PNA FISH results while 84 in the control group did not. Evaluable criteria were met in 53 patients in the PNA FISH group and 34 in the control group. When comparing the results obtained from using the PNA FISH assay with those for the control group, there was a significant reduction in median length of hospital stay from 6 to 4 days (P < 0.05, CI 0.95-1.87) and a trend towards less vancomycin usage with a decrease in associated hospital costs of approximately Dollars 4000 per patient. CONCLUSIONS: The PNA FISH assay is rapid, accurate and reliable and in association with an AMT could decrease hospital length of stay in patients with CoNS bacteraemia in non-intensive care unit settings and prevent excessive vancomycin usage.


Subject(s)
Bacteremia/microbiology , Staphylococcus/classification , Adult , Aged , Drug Utilization , Female , Hospitalization/economics , Humans , In Situ Hybridization , Length of Stay , Male , Middle Aged , Vancomycin/economics
18.
Arch Intern Med ; 166(5): 580-5, 2006 Mar 13.
Article in English | MEDLINE | ID: mdl-16534047

ABSTRACT

BACKGROUND: No simple, cost-effective methods exist to identify patients at high risk for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization outside intensive care settings. Without such methods, colonized patients are entering hospitals undetected and transmitting these bacteria to other patients. We aimed to develop a highly sensitive, simple-to-administer prediction rule to identify subpopulations of patients at high risk for colonization on hospital admission. METHODS: We conducted a prospective cohort study of adult patients admitted to the general medical and surgical wards of a tertiary-care facility. Data were collected using electronic medical records and an investigator-administered questionnaire. Cultures of anterior nares and the perirectal area were also collected within 48 hours of admission. RESULTS: Among 699 patients who enrolled in this study, 697 underwent nasal cultures; 555, perirectal cultures; and 553, both. Patient self-report of a hospital admission in the previous year was the most sensitive variable in identifying patients colonized with methicillin-resistant Staphylococcus aureus or with either organism (sensitivity, 76% and 90%, respectively). A prediction rule requiring patients to self-report having received antibiotics and a hospital admission in the previous year would have identified 100% of patients colonized with vancomycin-resistant enterococci. In the high-risk groups defined by the prediction rule, the prevalence of colonization by methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, or either organism were 8.1%, 10.2%, and 15.0%, respectively. CONCLUSION: Patients with a self-reported previous admission within 1 year may represent a high-risk group for colonization by methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci at hospital admission and should be considered for targeted active surveillance culturing.


Subject(s)
Carrier State/epidemiology , Methicillin Resistance , Staphylococcal Infections/diagnosis , Staphylococcus aureus , Carrier State/microbiology , Confidence Intervals , Female , Follow-Up Studies , Humans , Male , Maryland/epidemiology , Middle Aged , Nasal Cavity/microbiology , Prevalence , Prospective Studies , Risk Factors , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification
19.
Clin Infect Dis ; 41(7): 1064-7, 2005 Oct 01.
Article in English | MEDLINE | ID: mdl-16142677

ABSTRACT

Six cases of Candida dubliniensis fungemia were identified during an 8-month period in hospitalized patients with various conditions, including human immunodeficiency virus infection. Peptide nucleic acid fluorescent in situ hybridization analysis was used as a rapid and reliable test for differentiating C. dubliniensis from Candida albicans, making it feasible to determine the prevalence of C. dubliniensis fungemia.


Subject(s)
Candidiasis/epidemiology , Candidiasis/microbiology , Fungemia/epidemiology , Fungemia/microbiology , Adult , Antifungal Agents/therapeutic use , Candidiasis/drug therapy , Child, Preschool , Female , Fungemia/drug therapy , Hospitals , Humans , In Situ Hybridization, Fluorescence/methods , Male , Middle Aged , Peptide Nucleic Acids , Prevalence
20.
J Antimicrob Chemother ; 56(1): 139-45, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15917283

ABSTRACT

BACKGROUND: In 1995, beta-lactam inhibitor combinations replaced third-generation cephalosporins as empirical therapy in an effort to manage extended-spectrum beta-lactamase (ESBL) resistance. This study investigated the relationship between antibiotic usage and ESBL organisms from 1994 through 2002 using epidemiological and molecular analysis. METHODS: A case-control study of 119 patients with ESBL organisms and 132 patients with non-ESBL organisms was conducted. Demographics, co-morbidities, device utilization and antibiotic use were analysed for all patients and infected patients only (cases = 75, controls = 83). Both exposure and degree of exposure (in grams) to antibiotics were included. A dot blot hybridization technique was used to identify genes in plasmid extracts from the ESBL organisms. RESULTS: Ventilator days OR 1.1 (1.06, 1.15) P < 0.001, adult respiratory distress syndrome (ARDS) OR 3.1 (1.0, 9.7) P = 0.05, prior aminoglycoside use OR 2.7 (1.2, 6.1) P = 0.02, prior third-generation cephalosporin use OR 7.2 (2.6, 20) P < 0.001, and prior trimethoprim/sulfamethoxazole use OR 8.8 (3.1, 26) P < 0.001 were significantly associated with ESBL organisms by multivariate analysis. All models were concordant with a significant association of ventilator days, third-generation cephalosporins and trimethoprim/sulfamethoxazole with ESBL organisms. beta-Lactamase inhibitor combinations were not associated with ESBL organisms. Hybridization of plasmid extracts demonstrated that 95% of the ESBL organisms carried intI1, a mobile DNA element with a sulphonamide-resistance (R) gene and a frequent carrier of other R factors. Genes for specific types of trimethoprim-R and aminoglycoside-R were present in 26% and 40% of the extracts, respectively. CONCLUSIONS: These data indicate that, besides patient risk factors and third-generation cephalosporins, other antibiotics may provide selective pressures in maintaining ESBL organisms due to multiple resistance genes on plasmids. beta-Lactamase inhibitor combinations appear to be an acceptable substitute to third-generation cephalosporins in strategies to control ESBL organisms.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Infections/drug therapy , Bacterial Infections/etiology , beta-Lactamases/biosynthesis , Case-Control Studies , Cephalosporins/therapeutic use , Drug Resistance, Bacterial , Humans , Middle Aged , Multivariate Analysis , Respiration, Artificial/adverse effects , Risk Factors , beta-Lactamase Inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...